Nanoparticle albumin-bound paclitaxel (NAB-PTX) has been employed to deliver trastuzumab (T-mab) and pertuzumab (P-mab) for the treatment of HER2-positive primary breast cancer (PerSeUS-BC04) (166). This evidence concerns the gene ERBB2 and breast carcinoma.